Sino Biopharmaceutical Ltd (SBMFF) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,99%	1 093,81	+10,77	+0,99%	—	1 083,04	1 082,63	1 099,01	1 080,59	—	—
SIXC Communications SIXC Communications	SIXC +1,06%	608,77	+6,39	+1,06%	—	602,38	602,38	609,75	599,75	—	—
SIXE Energy SIXE Energy	SIXE +0,96%	1 254,81	+11,98	+0,96%	—	1 242,83	1 229,31	1 258,88	1 220,51	—	—
SIXI Industrials SIXI Industrials	SIXI +2,76%	1 761,11	+47,29	+2,76%	—	1 713,82	1 715,47	1 763,11	1 715,47	—	—
SIXM Financials SIXM Financials	SIXM +0,40%	642,58	+2,59	+0,40%	—	639,99	636,98	644,04	631,81	—	—
SIXR Staples SIXR Staples	SIXR +1,63%	851,13	+13,67	+1,63%	—	837,46	840,30	852,55	840,30	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,76%	217,98	+3,76	+1,76%	—	214,22	214,22	218,25	214,05	—	—
SIXT Technology SIXT Technology	SIXT +0,23%	3 211,83	+7,45	+0,23%	—	3 204,38	3 215,04	3 217,44	3 159,90	—	—
SIXU Utilities SIXU Utilities	SIXU +2,55%	948,98	+23,60	+2,55%	—	925,38	927,91	949,76	927,91	—	—
SIXV Health care SIXV Health care	SIXV +2,20%	1 474,52	+31,81	+2,20%	—	1 442,71	1 443,01	1 477,90	1 443,01	—	—
SIXY Discretionary SIXY Discretionary	SIXY +1,30%	2 392,12	+30,78	+1,30%	—	2 361,34	2 391,00	2 399,18	2 354,52	—	—

SBMFF:OTCMKTS

Sino Biopharmaceutical Ltd

0,76 USD

0,00%

(0,00) 1 D

15. apr., 11:31:08 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for SBMFF …

Markedsverdi

101,60 mrd.

Snittvolum

171,00

Volum

0,00

52 u høy

1,24 USD

52 u lav

0,49 USD

Beta

0,70

Utestående aksjer

18,75 mrd.

Antall ansatte

21k

Relaterte aksjer

Nyhetssaker

Fra kilder på nettet

thereporteronline

for 9 minutter siden

Wall Street mixed with most markets closed for May Day; US crude holds steady at $104 a barrel

TheStreet Pro

for 15 minutter siden

Trump Faces Iran Deadline After S&P 500 Record: 8 Key Items Shaping the Stock Market Friday

Yahoo Finance

for 18 minutter siden

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Manila Times

for 36 minutter siden

reAlpha (Nasdaq: AIRE) CEO and CFO to Present Company's Vertically Integrated Homebuying Vision at Two New York Conferences

Profil

Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia

Om Sino Biopharmaceutical Ltd

Administrerende direktørLi Yi

Ansatte21,4k

Grunnlagt2000

Hovedkontor-

Sektor-

Nettstedsbpgroup.com

Alle verdier i CNY	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	8,79 mrd.	8,79 mrd.	7,13 mrd.	7,13 mrd.
Varekostnad	1,54 mrd.	1,54 mrd.	1,31 mrd.	1,31 mrd.
Direkte driftskostnader	1,54 mrd.	1,54 mrd.	1,31 mrd.	1,31 mrd.
Utgifter til forskning og utvikling	-	-	2,93 mrd.	2,93 mrd.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	3,77 mrd.	3,77 mrd.	2,80 mrd.	2,80 mrd.
Driftskostnader	5,54 mrd.	5,54 mrd.	4,38 mrd.	4,38 mrd.
Totale driftskostnader	7,08 mrd.	7,08 mrd.	5,69 mrd.	5,69 mrd.
Driftsinntekter	1,70 mrd.	1,70 mrd.	1,44 mrd.	1,44 mrd.
Andre ikke-operasjonelle inntekter	40,54 mill.	40,54 mill.	97,99 mill.	97,99 mill.
EBT inkludert uvanlige elementer	2,98 mrd.	2,98 mrd.	488,22 mill.	488,22 mill.
EBT uten uvanlige elementer	2,72 mrd.	2,72 mrd.	1,55 mrd.	1,55 mrd.
Kostnad for inntektsskatt	490,66 mill.	490,66 mill.	323,77 mill.	323,77 mill.
Faktisk avgiftssats	16,45 %	16,45 %	66,32 %	66,32 %
Andre driftskostnader	1,77 mrd.	1,77 mrd.	−1,35 mrd.	−1,35 mrd.
Nettoinntekt	1,69 mrd.	1,69 mrd.	−522,62 mill.	−522,62 mill.
Netto fortjenestemargin	19,28 %	19,28 %	−7,33 %	−7,33 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	989,64 mill.	989,64 mill.	196,36 mill.	196,36 mill.
Rentekostnader	−61,60 mill.	−61,60 mill.	−77,56 mill.	−77,56 mill.
Netto rentekostnader	928,03 mill.	928,03 mill.	118,80 mill.	118,80 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	1,97 mrd.	1,97 mrd.	1,71 mrd.	1,71 mrd.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning